Patents Assigned to Obalon Therapeutics, Inc.
-
Patent number: 10874537Abstract: Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.Type: GrantFiled: August 24, 2018Date of Patent: December 29, 2020Assignee: Obalon Therapeutics, Inc.Inventors: Mark C. Brister, Kaushik A. Patel, Andrew P. Rasdal, Nelson Quintana, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Amy D. L. VandenBerg
-
Patent number: 10772752Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and devices for inflating and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.Type: GrantFiled: October 24, 2017Date of Patent: September 15, 2020Assignee: Obalon Therapeutics, Inc.Inventors: Mark C. Brister, Neil R. Drake, Daniel J. Proctor, Madeline Campbell
-
Patent number: 10773061Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.Type: GrantFiled: May 29, 2018Date of Patent: September 15, 2020Assignee: Obalon Therapeutics, Inc.Inventors: Mark C. Brister, Andrew P. Rasdal, Neil R. Drake, Amy D. L. VandenBerg
-
Patent number: 10709592Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, locating, tracking, monitoring, deflating, and retrieving the same are provided.Type: GrantFiled: October 27, 2017Date of Patent: July 14, 2020Assignee: Obalon Therapeutics, Inc.Inventors: Mark C. Brister, Neil R. Drake, Sheldon Nelson
-
Patent number: 10675165Abstract: Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.Type: GrantFiled: November 7, 2017Date of Patent: June 9, 2020Assignee: Obalon Therapeutics, Inc.Inventors: Mark C. Brister, Kaushik A. Patel, Andrew P. Rasdal, Nelson Quintana, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Amy D. L. VandenBerg
-
Patent number: 10660778Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided. More particularly, apparatuses and methods for enabling volume-occupying intragastric devices to pass through the digestive system are provided.Type: GrantFiled: June 14, 2017Date of Patent: May 26, 2020Assignee: Obalon Therapeutics, Inc.Inventors: Eleanor McCarthy, Mark C. Brister, Antonio C. Llevares, Betty Wong
-
Patent number: 10617545Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.Type: GrantFiled: May 25, 2016Date of Patent: April 14, 2020Assignee: Obalon Therapeutics, Inc.Inventors: Mark C. Brister, Neil R. Drake, Antonio C. Llevares, Sheldon Nelson, Daniel J. Proctor, Andrew P. Rasdal, Keoni John Sundseth, Amy D. L. VandenBerg, Betty Wong
-
Patent number: 10610396Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.Type: GrantFiled: February 27, 2018Date of Patent: April 7, 2020Assignee: Obalon Therapeutics, Inc.Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D. L. VandenBerg, Antonio C. Llevares, Josefina Nider
-
Patent number: 10537453Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.Type: GrantFiled: October 26, 2016Date of Patent: January 21, 2020Assignee: Obalon Therapeutics, Inc.Inventors: Mark C. Brister, Betty Wong, Neil R. Drake, Sheldon Nelson, Daniel J. Proctor, Kate Sapp, Eleanor McCarthy
-
Patent number: 10463520Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.Type: GrantFiled: August 29, 2017Date of Patent: November 5, 2019Assignee: Obalon Therapeutics, Inc.Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D. L. VandenBerg, Antonio C. Llevares, Josefina Nider
-
Patent number: 10350100Abstract: Devices and methods for treating obesity are provided, including intragastric devices and methods of fabricating, deploying, inflating, locating, tracking, monitoring, deflating, and retrieving the same. In one embodiment, a device includes a balloon capsule having a distal end, a catheter having a proximal end and a distal end, a connector, a light sensor, and a balloon valve. At least one optical fiber extends along the length of the interior of the catheter and through the valve such that a distal end of the optical fiber is positioned at a distal end of the balloon capsule when the catheter is placed within the balloon capsule, and such that a proximal end of the optical fiber can be received by the light sensor.Type: GrantFiled: March 16, 2017Date of Patent: July 16, 2019Assignee: Obalon Therapeutics, Inc.Inventors: Sheldon Nelson, Neil R. Drake
-
Patent number: 10335303Abstract: Devices and methods for treating obesity are provided. More particularly a device for assisting a patient in swallowing an intragastric balloon is provided, comprising an elongate tube, a gastric balloon assembly reversibly attached to an orifice of the elongate tube and comprising an inflation catheter engaged with a gastric balloon, a handle member, and an engagement subassembly comprising a female portion and a male portion and configured and arranged for threading the inflation catheter into and engaging the elongate tube.Type: GrantFiled: November 4, 2016Date of Patent: July 2, 2019Assignee: Obalon Therapeutics, Inc.Inventors: Mark C. Brister, Neil R. Drake
-
Patent number: 10327936Abstract: An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.Type: GrantFiled: December 5, 2016Date of Patent: June 25, 2019Assignee: Obalon Therapeutics, Inc.Inventors: Mark C. Brister, Nelson Quintana, Kaushik A. Patel, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Andrew P. Rasdal, Amy D. L. VandenBerg
-
Patent number: 10264995Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, locating, tracking, monitoring, deflating, and retrieving the same are provided.Type: GrantFiled: December 3, 2014Date of Patent: April 23, 2019Assignee: Obalon Therapeutics, Inc.Inventors: Mark C. Brister, Neil R. Drake, Sheldon Nelson, Daniel J. Proctor
-
Patent number: 10085865Abstract: Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.Type: GrantFiled: May 28, 2015Date of Patent: October 2, 2018Assignee: Obalon Therapeutics, Inc.Inventors: Mark C. Brister, Kaushik A. Patel, Andrew P. Rasdal, Nelson Quintana, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Amy D. L. VandenBerg
-
Publication number: 20180110640Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.Type: ApplicationFiled: May 25, 2016Publication date: April 26, 2018Applicant: Obalon Therapeutics, Inc.Inventors: Mark C. Brister, Neil R. Drake, Antonio C. Llevares, Sheldon Nelson, Daniel J. Proctor, Andrew P. Rasdal, Keoni John Sundseth, Amy D.L. VandenBerg, Betty Wong
-
Patent number: 9895248Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, locating, tracking, monitoring, deflating, and retrieving the same are provided.Type: GrantFiled: October 7, 2015Date of Patent: February 20, 2018Assignee: Obalon Therapeutics, Inc.Inventors: Mark C. Brister, Neil R. Drake, Sheldon Nelson
-
Patent number: 9827128Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.Type: GrantFiled: September 21, 2015Date of Patent: November 28, 2017Assignee: Obalon Therapeutics, Inc.Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D. L. VandenBerg, Antonio C. Llevares, Josefina Nider
-
Patent number: 9662239Abstract: Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.Type: GrantFiled: May 4, 2016Date of Patent: May 30, 2017Assignee: Obalon Therapeutics, Inc.Inventors: Mark C. Brister, Paul D. Faucher, Neil R. Drake, Andrew P. Rasdal, Matthew S. Lake, Dubravka Markovic, Amy D. L. VandenBerg, Antonio C. Llevares, Josefina Nider
-
Patent number: 9539132Abstract: An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.Type: GrantFiled: August 26, 2014Date of Patent: January 10, 2017Assignee: Obalon Therapeutics, Inc.Inventors: Mark C. Brister, Nelson Quintana, Kaushik A. Patel, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Andrew P. Rasdal, Amy D.L. VandenBerg